Advertisement
A roadmap for resuming elective surgery after new cases of COVID-19 begin to wane is presented in a joint statement published by the American College of Surgeons and other societies.

Roadmap Developed for Resuming Elective Surgery During COVID-19

0
Sustained drop in rate of new COVID-19 cases for at least 14 days required to resume elective surgery
Acute respiratory distress syndrome due to COVID-19 is associated with neurologic features

Neurologic Features Tied to ARDS in Severe COVID-19 Described

0
Unclear whether critical illness, medication, infection itself may cause encephalopathy, agitation, confusion
Anesthesiologists on the front lines of treating surgical COVID-19 patients in Turkey are generally knowledgeable about airway management

Survey Finds Anesthesiologists Prepared for COVID-19 Patients

0
Authors say easy-to-understand algorithms, training for anesthesiologists could improve safety
Diabetes and/or uncontrolled hyperglycemia occur frequently among hospitalized patients with COVID-19 and are associated with worse outcomes

COVID-19 Outcomes Worse With Diabetes, Hyperglycemia

0
Length of stay longer, mortality higher for those with diabetes and/or acutely uncontrolled hyperglycemia
The rate of infection with influenza

Infection Rate Up Prior to Detection of Malignant Cancer

0
Increased odds of influenza, gastroenteritis, hepatitis, pneumonia seen one year before detection
Changes to health care have been reported among patients with rheumatic diseases during the COVID-19 pandemic

COVID-19-Linked Changes Reported in Rheumatic Disease Patient Care

0
Forty-two percent of patients report change in care in previous two weeks
A review of vaping products has been delayed by the COVID-19 outbreak

COVID-19 Pandemic Delays FDA Review of Vaping Products

0
Federal court has granted FDA request to delay May 12 deadline to Sept. 9
Inconclusive findings from a study investigating the antiviral drug remdesivir as a treatment for COVID-19 were posted to the World Health Organization website "prematurely

Premature Posting of Remdesivir Findings Were ‘Inconclusive’

0
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'
Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use

FDA Warns About Treating COVID-19 With Unproven Drugs

0
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension

HTN, Obesity, Diabetes Common in U.S. COVID-19 Patients

0
Twenty-one percent of hospitalized patients died; 88.1 percent requiring mechanical ventilation died